✦ LIBER ✦

PCNI8 A COST COMPARISON OF GEMZAR PLUS CISPLATIN WITH OTHER NOVEL AGENTS IN THE TREATMENT OF NON-SMALL CELL LUNG CANCER IN ITALY

✍ Scribed by A Kielhorn; G Stynes; S Bhalla; D Tilden

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PCNI6 COMPARATIVE COSTS OF GEMCITABINE/C

✍ H Bischoff; M Hamann; G Stynes; S Bhalla; D Tilden; A Kielhorn 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 63 KB

Economic evaluation of Gemzar/cisplatin

✍ N. Botwood; J. McKendrick; M. Aristides; M. Lees; N. Maniadakis; W. Wein; D. Ste 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 191 KB

PCNI7 DOES GEMCITABINE PLUS CISPLATIN PR

✍ J Watkins; A Kielhorn; S Bhalla; D Tilden; G Stynes 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 63 KB

Comparison of vindesine plus cisplatin o

📂 Article 📅 1986 🏛 Elsevier Science 🌐 English ⚖ 98 KB

Paclitaxel plus cisplatin in the treatme

✍ Tong Maorong; Cao Ehong; Xia Xirong; Shi Yi; Kang Xiaoming 📂 Article 📅 1996 🏛 Chinese Anti-Cancer Association 🌐 English ⚖ 149 KB

PCNI5 GEMZAR RETROSPECTIVE ECONOMIC ANAL

✍ R Launois; S Avoinet; K Le Lay; D Tilden; S Bhalla; A Kielhorn; N Chemali 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 81 KB